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       Chapter 3 




Recreational use of ecstasy, or 3,4-methylenedioxymethamphetamine (MDMA), has 
become more widespread during the last decennia. There is much concern about the long-
lasting consequences of MDMA use. Several studies in both animals and humans have 
indicated that MDMA selectively decreases 5-HT functioning in the brain. To investigate 
whether gender differences exist in the acute and long-term consequences of MDMA 
(ab)use, in the present research sexes are compared for their acute and long-term 
hyperthermic response and long- term serotonergic depletion after MDMA. Female and 
male rats were injected 3 times with 3 hours interval with saline, 0.3, 1, 3 or 9 mg/kg 
MDMA. MDMA was administered i.p. at an ambient temperature of 25 ˚C. Acute 
and long-term effects on body temperature were measured with telemetry. Four weeks after 
MDMA administration animals receiving 3 x 9 mg/kg were decapitated and brains 
processed for monoamine analysis. After the highest dose, MDMA elicited not only an 
acute but also a long-lasting hyperthermia, which was much higher in males than in 
females and persistent for males the whole 4-week period of sampling. Whereas no gender 
differences were found in the 5-HT depleting effect of MDMA, a striking difference was 
observed in 5-HIAA concentrations. In the majority of brain areas 5-HIAA levels 
decreased only in males, suggesting a lasting increase in 5-HT turnover in females. To 
exclude a role for the difference in hyperthermic response between both genders on the 5-
HT depletion, in an additional experiment males and females were matched on the 
magnitude of the hyperthermic response. 5-HT depletion was not different between genders 
with similar hyperthermia. Also in this experiment 5-HIAA levels only decreased in 
males suggesting an increased 5-HT turnover in females 4 weeks after MDMA 
administration. In conclusion, males are more susceptible for the hyperthermic effects than 
females, but no long-term differences were found in the level of 5-HT depletion. Whether 
the lasting increase in 5-HT turnover in females is indicative of an increased vulnerability 
to the negative consequences of MDMA on 5-HT functionality has to be addressed in 
further studies.  






The popularity of the psychostimulant ecstasy (3,4-methylenedioxy-
methamphetamine; MDMA) has increased during the last decades. One of 
the acute dangers of ecstasy (ab)use is the occurrence of a hyperthermia (for 
example see (Schmidt et al., 1990; Nash, Jr. et al., 1988; Dafters, 1994; 
O'Shea et al., 1998; Malberg et al., 1996; Freedman et al., 2005), which may 
lead to lethality (Dowling et al., 1987; Chadwick et al., 1991). Maybe even 
more reason for concern is the long-lasting, possibly neurotoxic 
consequences of MDMA for the serotonergic system. Several preclinical 
studies have demonstrated that MDMA evokes a persistent decrease in 
serotonin and 5-hydroxyindoleacetic acid (5-HIAA), a reduction in 
tryptophan hydroxylase (TPH) activity and a reduction of serotonin 
transporter (SERT) activity and expression and long-term impairment of 
anterograde transport in serotonin axons (Battaglia et al., 1987; Hewitt & 
Green, 1994; Schmidt & Taylor, 1987; Stone et al., 1986; Xie et al., 2006; 
Sharkey et al., 1991; Stone et al., 1987b; Buchert et al., 2004; Ricaurte et al., 
2000; Colado et al., 1993; Semple et al., 1999; Schmidt & Taylor, 1988; 
Callahan et al., 2001). Although clinical studies on this matter are less 
conclusive, there is increasing evidence that MDMA can be toxic for the 
human brain as well (Reneman et al., 2001; de Win et al., 2004; McCann et al., 
2000; Reneman et al., 2006; Turner & Parrott, 2000; Grob, 2002). 
In preclinical psychopharmacological research females are often not 
included because one has to control for the hormonal fluctuations due to 
the estrous cycle. However, preclinical and clinical studies emphasize the 
importance of sex differences in the pharmacokinetic and 
pharmacodynamic responses to many drugs of abuse, including alcohol, 
nicotine and psychostimulants like cocaine and amphetamine (Becker et al., 
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2001; Brady & Randall, 1999; Carroll et al., 2004; Lynch et al., 2002). 
Evidence suggests that females are more vulnerable than males to the 
reinforcing effects of psychostimulants (Liechti et al., 2001).    
In view of the evidence that the use of ecstasy increased significantly among 
females together with the general increasing popularity of ecstasy (Allott & 
Redman, 2007) it is important to consider gender as a modulatory factor in 
the long-lasting effects of MDMA on serotonergic functioning. Therefore, 
the present study aimed at the question of gender differences in the long-
lasting serotonergic neurotoxic consequences.  
Data from studies in humans suggest indeed a gender difference: females 
seem to be more susceptible than males to deficiencies in 5-HT functioning 
after ecstasy use (McCann et al., 1994; Buchert et al., 2004; Croft et al., 2001; 
Reneman et al., 2001). So far, animal studies have found no (consistent) 
difference between male and female rats in depletion of 5-HT and 5-HIAA 
levels after MDMA administration (Chu et al., 1996; Koenig et al., 2005; 
McNamara et al., 1995; Walker et al., 2007). Regarding gender differences in 
MDMA-induced changes in body temperature and behavioral locomotor 
response, conflicting results are reported (Walker et al., 2007; Palenicek et al., 
2005; Koenig et al., 2005; Colado et al., 1995; McNamara et al., 1995; Fonsart 
et al., 2008).  
The present study investigated whether male and female rats differed in the 
acute hyperthermic and long-term body temperature and 5-HT depleting 
effects of MDMA. The study was divided into two parts. In the first part of 
the experiment it was investigated whether there are differences in acute and 
long-term body temperature effects and in the long-term serotonergic 
depletion between male and female rats after MDMA administration. 
Different dosages of MDMA were administered and the MDMA-induced 
hyperthermic response was measured in both males and females. Body 




temperature was measured using biotelemetry, to assure body temperature 
sampling in a stress-free manner. To control for interaction effects with 
body temperature, in a second experiment male and female rats were 
matched for their acute MDMA-induced hyperthermic response and it was 
investigated whether these male and female rats differed in the induced 
long-term serotonin depletion.  
 
 
MATERIALS AND METHODS 
 
Subjects 
All experiments have been approved by the animal experiments committee 
of the University of Groningen. Wild-type Groningen rats were used. Their 
ancestors were originally wild-trapped animals, subsequently bred in our 
laboratory for more than 31 generations. Room temperature was 21 ºC, 
except during MDMA administration. Males and females were housed in 
separate rooms. All rats were individually housed in clear Perspex cages (31 
x 15 x 14 cm) with sawdust bedding in a room with 12:12 light:dark cycle 
(lights on at 8:00h). Food (chow) and water was available ad libitum 
throughout the whole experiment.  
 
In the first experiment 45 female and 50 male Wild-type Groningen rats 
(Rattus norvegicus) of 10 weeks old (male 370 ± 3.8 g, females 210 ± 2.2 g at 









A radio-telemetry system (Data Sciences, St. Paul, MN) was used for stress-
free monitoring of body temperature. At least 14 days before MDMA 
administration, in 28 males and 30 females transmitters (TA10TA-F40; 
sensitivity: 0.1 ºC) were implanted intraperitoneally using O2-isoflurane 
anaesthesia. Temperature was measured every ten minutes throughout the 
entire experiment. 
The cages of the rats were placed on receiver plates and the signal was 
collected and analyzed using the DSI Dataquest® A.R.T. Acquisition 
System.  
To determine the long-term effect of MDMA on body temperature, data 
averages of 12 hours (matching the light and the dark period) were 
calculated. 
 
MDMA/saline injections  
3,4-Methylenedioxymethamphetamine (± MDMA-HCl, 99.6% obtained 
from the Dutch Forensic Institute, The Netherlands) was injected 
intraperitoneally (i.p.) three times with intervals of three hours (“binge 
administration”) during the light phase. The first injection was given 1.5 
hours after lights went on. MDMA was given to both females and males at 
concentrations of 0.3 (8 males, 9 females), 1 (9 males, 9 females), 3 (8 males, 
9 females) and 9 (15 males, 9 females) mg/kg MDMA, solved in 1 ml ultra 
purified water. Control animals were saline injected (9 males, 9 females). 
Ambient temperature was 25 ± 0.5 ºC), starting from 1.5 h before the first 








Analysis of brain monoamine concentrations 
It has been demonstrated that MDMA-induced 5-HT depletion only occurs 
when acutely a significant hyperthermic response could be observed (for 
review see (Green et al., 2003). Since the part of aim of the present study 
was to investigate whether there are gender differences in the serotonergic 
depletion after MDMA, only of male and female rats administered saline or 
3 x 9 mg/kg MDMA (resulting in a clear hyperthermic response) 
monoamine concentrations were measured in the brain. 
Four weeks after treatment these male and female rats were decapitated 
under brief CO2 anesthesia in early light phase. From these animals, 
prefrontal cortex (PFC), striatum, hippocampus, cerebellum, brainstem 
(Bregma -8.50 mm to 16 mm), hypothalamus, parietal cortex and septum 
were dissected on a chilled plate, immediately snap frozen in Eppendorf 
vials in liquid nitrogen and stored at -80 ºC. For determination of 5-HT, 5-
HIAA, dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), 
homovanillic acid (HVA) and noradrenalin (NA) in these areas, High 
Performance Liquid Chromatography (HPLC) was used. For this, samples 
were homogenized in 0.5 ml 0.1 M perchloric acid and centrifuged at 14000 
rpm for 10 min at 4 ˚C. Supernatant was removed and analyzed for 5-HT, 
5-HIAA, DA, DOPAC, and NA concentrations. For determination of the 
monoamines and their metabolites, 100 µl was injected onto a reversed 
phase Gemini C18 column (150 x 4.6 mm, 5µm particle size), connected to 
a detector (ESA coulochem model 5100A) with a 5011A detector cell. A 
difference in potential of 340 mV was set (the potential of one electrode 
was 0 mV and the other was 340 mV). The mobile phase consisted of 62.7 
nM Na2HPO4, 40.0 nM citric acid, 0.27 mM EDTA, 4.94 mM HSA, 10% 
methanol at pH 4.1 with a flow of 0.5 ml/min. Known amounts of 5-HT, 
5-HIAA, DA, DOPAC, HVA (Sigma Chemicals) and NA (Research 
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Biochemicals International) were run throughout the whole procedure for 
standardization. Monoamine levels were calculated as ng/g tissue.  
 
The second experiment was performed to control for possible difference on 
serotonergic depletion between genders due to a difference in their MDMA-
induced hyperthermic response. Therefore body temperature of both sexes 
was matched on peak temperatures. We chose to match males to the 
hyperthermic response of females that received 3 x 9 mg/kg MDMA in the 
first experiment, instead of matching females to the hyperthermic response 
of males that receiving 3 x 9 mg/kg MDMA, since the hyperthermic 




At least 14 days before MDMA administration, in 10 male rats transmitters 
(TA10TA-F40; sensitivity: 0.1 ºC) were implanted intraperitoneally (i.p.) 
using O2-isoflurane anaesthesia. Temperature was measured every ten 
minutes throughout the whole experiment. The cages of the rats were 
placed on receiver plates and the signal was collected and analyzed using the 
DSI Dataquest® A.R.T. Acquisition System.  
 
MDMA administration 
The 10 male rats (364 ± 8.7 g at the day of MDMA administration) were 
injected 6 mg/kg MDMA (i.p.) three times with intervals of three hours 
(“binge administration”) during the light phase. The first injection was given 
1.5 hours after lights went on. Ambient temperature was 25 ºC (± 0.5), 
starting from 1.5 h before the first injection until 3 hours after the last 
injection. 




Analysis of brain monoamine concentrations 
Four weeks after the injections animals were decapitated under brief CO2 
anesthesia in early light phase. From all animals, prefrontal cortex (PFC), 
striatum, hippocampus, cerebellum, brainstem, hypothalamus, parietal 
cortex and septum were dissected on a chilled plate. Brain areas were 
removed and snap frozen in liquid nitrogen and stored at 80 ºC. 5-HT and 
5-HIAA brain concentrations were measured as described previously. 
 
Statistical analysis  
SPSS 14.0 for Windows was employed to analyze the data statistically. Acute 
body temperature response (Area Under the Curve, AUC) was analyzed 
using a two-factor ANOVA with treatment (5 levels) and gender (2 levels) 
as between-subject factors. The long-term body temperature was analyzed 
using repeated-measures ANOVA with treatment (5 levels) and gender (2 
levels) as between-subject factors. In case of significant interaction effects, 
post hoc analyses were performed using an independent t-test to reveal the 
differences between both genders for each dose. A one-way ANOVA was 
used to reveal for each gender separately the differences between the several 
doses. 
Lethality rate of males and females for each dose was statistically analyzed 
using logistic regression. In experiment 1 and 2, monoamine concentrations 
were statistically analyzed using a two-factor ANOVA with treatment (2 
levels) and gender (2 levels) as between-subject factors. In case of a 
significant interaction effect post hoc analysis was performed using an 
independent t-test to reveal the differences between both genders for each 
dose.  
In experiment 2 body temperature response was analyzed by repeated 
measurements ANOVA with gender (2 levels) as between-subject factor. In 
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case of a significant main and/or interaction effect, post hoc analysis was 








Acute effect of MDMA on body temperature 
MDMA induced a significant hyperthermic response in rats administered 3 
x 9 mg/kg MDMA (main dose effect F(4,47)=30.954, p<0.0001). When 
taking also gender into account, the two factor ANOVA revealed a 
significant gender x dose interaction effect (F(4,47)=8.388, p<0.0001). As 
shown in figure 1a and 1b, the hyperthermic response was stronger in male 
than in female rats (t(9)=-4.990, p<0.001). Furthermore, 3 x 3 mg/kg 
MDMA only induced a significant hyperthermic response in males 
(F(4,23)=112.179, p<0.0001), which was lower than the hyperthermic 
response observed after 3 x 9 mg/kg MDMA. In addition, baseline body 
temperature was higher in males than in females (t(10)=-3.240, p<0.01). 
 
Lethality 
Employing logistic regression using the model Y = LOG (p/(p-1) = ax+b, 
(p = chance of  a rat dying and a zero model was used for fit, with y = 
constant) revealed that dosage (X2 = 30.88, p <0.0001) of  MDMA and 
gender (X2 = 6.13, p <0.05) together determined survival rate, indicating 
that significantly more males than females died after receiving 3 x 9 mg/kg 
MDMA (see table 1). 





























Figure 1a) Average total body temperature response (+ s.e.m.) over the first nine hours after the 
first MDMA injection. Male and female rats were injected 3 x 0.3, 3 x 1, 3 x 3 or 3 x 9 
mg/kg MDMA or saline. * p<0.05. b) Average body temperature (+ s.e.m.) of male and 
female rats over time. Rats were injected three times with 0 or 9 mg/kg MDMA. Injections were 
administered at time point 0, 3 and 6. Arrows indicated time of injection. *control male vs. 9 
mg/kg male p<0.05; #control female vs. 9 mg/kg female p<0.05; $9 mg/kg male vs. 9 mg/kg 
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Table 1 Lethality of male and female rats after the highest dose (3 x 9 mg/kg) of MDMA. 
 9 mg/kg 
 Alive % survival    
Males 6 out of 15 40%    
Females 8 out of 9 89%    
 
Long-term effect on body temperature 
MDMA treatment resulted in a differential body temperature response in 
male and female rats (treatment x sex interaction (F(4,2544)=2.335, 
p<0.0001)). Post-hoc analysis revealed that male and female rats receiving 3 
x 9 mg/kg MDMA were also hyperthermic the day after MDMA injections. 
Female rats receiving 3 x 9 mg/kg MDMA were hyperthermic in the light 
phase one day after repeated MDMA treatment, whereas male rats stayed 
hyperthermic until 2.5 days after MDMA administration (figure 2). Within 
these 2.5 days body temperature in the light phase was higher than in the 
dark phase in male rats. MDMA treatment of 3 x 9 mg/kg in male rats 
increased body temperature during the dark phase (active period of the day) 
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Figure 2 Average body temperature (+ s.e.m.) of male and female rats per twelve hours during 
28 days. At day zero repeated MDMA (3 x 9 mg/kg) or saline injections were given. Dark 
symbols represent the average body temperature during the dark phase. Light symbols represent the 
average body temperature during the light phase. *control male vs. 9 mg/kg male p<0.05;        
#control female vs. 9 mg/kg female p<0.05; $9 mg/kg male vs. 9 mg/kg female p<0.05;     
&control male vs. control female p<0.05.  
 
Monoamine concentrations 
3 x 9 mg/kg MDMA induced 5-HT in all brain areas (main treatment effect, 
F(1,28)>9.018, p<0.05). Male and female rats did not differ in the induced 
5-HT depletion (no significant treatment x gender interaction, 
(F(1,28)<2.808, p>0.05) (figure 3a). 
Furthermore, MDMA evoked a 5-HIAA depletion in all brain areas except 
septum, cerebellum and brain stem (main treatment effect, F(1,32)>7.107, 
p<0.05). When gender was also taken into account, significant larger 5-
HIAA depletion was found in the hippocampus, septum, cerebellum, 
brainstem and hypothalamus of male rats (treatment x gender interaction 
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(F(1,28)>4.739, p<0.05) (figure 3b). Baseline concentrations of 5-HT did 
not differ between genders in all brain areas (t(16)<1.529, p>0.05) (table 2). 
Female rats had a significant higher baseline 5-HIAA concentration in 
hippocampus (t(16)=3.456, p<0.05, septum (t(16)=2.728, p<0.05, 
cerebellum (t(16)=2.2886, p<0.05 and brain stem (t(16)=2.290, p<0.05 
(table 2). MDMA did not induce a depletion of DA, DOPAC, HVA and 
NA levels in any of the measured brain areas (data not shown).  
 
Table 2 Baseline 5-HT and 5-HIAA tissue concentrations (±  s.e.m.) for male and female 








                                 5-HT concentration (ng/g tissue)              
























689.9 ±  
46.30 
591.5 ±  
95.45 
Female 522.0 ±  
50.04 
311.38 ±  
17.76 
84.57 ±  
40.43 




559.1 ±  
32.22 
729.6 ±  
97.34 
443.7 ±  
34.14 
























490.9 ±  
30.34 
530.3 ±  
49.24 
Female 347.6 ± 
32.31 
366.48 ±  
14.85 
244.1 ±  
23.11 




425.2 ±   
12.39 
518.0 ±  
30.90 
588.5 ±  
59.19 





























Figure 3 Average % of a) 5-HT and b) 5-HIAA tissue concentration (+ s.e.m.) relative to 
control were measured in eight different brain areas in male and female rats, four weeks after 










The results of experiment 1 showed that MDMA induced a higher acute 
hyperthermia in males than in females and that no sex differences were 
found in serotonin markers in the brain.  As explained in the materials and 
methods, in this experiment we aimed to match males and female for their 
hyperthermic response to MDMA and investigated the long-term effect on 
the serotonergic system in the brain. Since in experiment 1 MDMA only 
resulted in a depletion of 5-HT and 5-HIAA concentrations, DA, DOPAC, 
HVA and NA concentrations were not analyzed. 
 
Matching of the acute body temperature response of male and female 
rats  
MDMA induced a hyperthermic response in male and female rats, with 
males having a higher body temperature than females (gender x dose 
interaction effect (F(1,1488)=2.214, p<0.0001)) at the time points indicated 
in figure 4. Importantly, no gender differences in peak temperature 
responses were observed.  
 
5-HT and 5-HIAA analysis  
Statistical analysis revealed that MDMA induced a significant depletion in 5-
HT concentrations in all brain areas except in PFC, hypothalamus and brain 
stem (main treatment effect, F(1,32)>4.571, p<0.05). Similar to experiment 
1, the magnitude of the 5-HT depletion did not differ between both genders 
except in the PFC and hypothalamus (gender x treatment interaction effect, 
F(1,32)=14.388, p<0.01; F(1,32)=7.455, p<0.01 respectively) (figure 5a). 
Post hoc analysis revealed that MDMA induced only a 5-HT depletion in 
females in the PFC (t(16)=3.841, p<0.01) and hypothalamus (t(16)=658, 
p<0.0001) (figure 5a). MDMA induced a 5-HIAA depletion in all brain 




areas except PFC and brain stem (main treatment effect F(1,32)>5.031, 
p<0.05). The magnitude of the induced 5-HIAA depletion differed between 
both genders in the hippocampus, septum, cerebellum, brain stem and 
striatum (gender x treatment interaction F(1,32)>4.697, p<0.05) (figure 5b). 
Post hoc analysis revealed that in these brain areas MDMA only induced a 
















Figure 4 Average body temperature (+ s.e.m.) of male and female rats over time. Rats were 
injected three times with 0 or 9 mg/kg MDMA. Injections were administered at time point 0, 3 
and 6 hours. Arrows indicated time of injection. *control male vs. 6 mg/kg male p<0.05;        
#control female vs. 9 mg/kg female p<0.05; $=6 mg/kg male vs. 9 mg/kg female p<0.05;   
&control male vs. control female p<0.05. Control male, control female and female 9 mg/kg were 


































Figure 5 Average % of a) 5-HT and b) 5-HIAA tissue concentration (+ s.e.m.) relative to 
control were measured in eight different brain areas, four weeks after repeated saline or MDMA 











The present study aimed to reveal gender differences in acute hyperthermia, 
lasting temperature regulation and monoamine depletion after MDMA 
treatment, using several dosages of MDMA. MDMA induced a much 
stronger acute hyperthermic response in male rats compared to female rats 
following treatment with 3 x 9 mg/kg MDMA and a higher lethality rate. 
This indicates that male rats are more vulnerable for the acute hyperthermic 
and lethal effects of MDMA than female rats. Our finding is in agreement 
with previous studies (Koenig et al., 2005; Fonsart et al., 2008; Wyeth et al., 
2009). Furthermore, the long-lasting increase in body temperature observed 
in only in male rats receiving the highest dose of MDMA indicates that male 
rats are also more vulnerable for the long-term hyperthermic effects than 
female rats.  
Furthermore, male and female rat do not differ in the magnitude of the 
MDMA-induced 5-HT depletion, which suggests there is no gender 
difference in the neurotoxic effects. A striking observation, however, was 
that 5-HIAA depletion was only observed in males. This result suggests that 
MDMA induced a long-lasting increase in 5-HT turnover in females. The 
implication of this increased turnover in females with regard to gender 
specific vulnerability to the possible neurotoxic effects of MDMA remains 
to be investigated. 
Body temperature is known to fluctuate during the day. Normally, body 
temperature in rats is higher during the active period (dark phase) of the day 
and lowers during the inactive period (light phase) of the day. Strikingly, up 
to 3 days after MDMA treatment in both genders the elevated body 
temperature is higher in the light-phase than in the dark phase. This might 
indicate that MDMA induces a temporal shift in circadian rhythmicity. 
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Indeed, there is evidence indicating that MDMA can induce abnormalities in 
sleep and circadian patterns (Balogh et al., 2004; McCann & Ricaurte, 2007) 
in humans and rodents.  
Two points for consideration come up with regard to the performed 
experiment. Firstly, mortality rates show that 2/3 of the males died after 
receiving 3 x 9 mg/kg MDMA. This might have caused a bias in the 
monoamine analysis. It is possible that the male rats that died after the 
MDMA injections are the rats that would also have the largest 5-HT 
depletion. The surviving rats might be relatively resistant to the MDMA-
induced 5-HT depletion. If this would be true, it would result in an 
underestimation of the serotonergic depletion in males that received 3 x 9 
mg/kg MDMA and a biased conclusion regarding the possible gender 
differences in vulnerability for MDMA induced neurotoxicity. Importantly, 
after administration of 3 x 6 mg/kg MDMA to male rats all rats survived, 
resulting in an unbiased gender comparison. 
Another point may be the difference in body weight between males and 
females. In the present study male rats are heavier than females (about 160 
gram difference). This might have resulted in higher peripheral and brain 
concentrations of MDMA in males. Higher circulating concentrations of 
MDMA might account for the observed difference in the acute 
hyperthermic response. However, recent evidence indicates difference in the 
thermogenic response. Females seem to be less vulnerable for the induction 
of a hyperthermic response by MDMA due to differences in their 
thermoregulatory abilities (Wyeth et al., 2009). 
In conclusion, males seem to be more at risk of developing an acute, 
potential lethal, MDMA-induced hyperthermic response than females. With 
and without matching of the hyperthermic response genders seem to be 
equally vulnerable for the evoked 5-HT depletion. However, it seems that 




females compensate for the initial loss of 5-HT by increasing the 5-HT 
turnover. It remains to be addressed in further studies what the functional 
consequences are of a lasting increase in serotonin turnover in an MDMA 
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